P1-180: Protein expression and gene amplification of epidermal growth factor receptor in non:small cell lung cancer: correlation with chemoresponse to gefitinib therapy  by Yoo, Jinyoung et al.
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Copyright © 2007 by the International Association for the Study of Lung CancerS808
Coexistence of MALT lymphoma with carcinomas was seen primarly 
in gastric lesions associated with H. Pylori infections. To our knowl-
edge only one case was reported with synchronous pulmonary adeno-
carcinoma and MALT type extranodal marginal zone lymphoma.
Case Report: A 49 years old male presented with back pain, weight 
loss and fatique. Chest x-ray revealed an increased density suggest-
ing a mass localized to superior zone of left lung. Systemic radiologic 
examination of the patient did not reveal any other mass lesion. Endo-
scopic examination of upper gastrointestinal system revealed gastric 
ulcer. The biopsy taken from the stomach and duodenum showed 
MALT lymphoma in both locations. He underwent an exploratory chest 
operation, during which a mass lesion comletely invading thorasic 
outlet and a second mass lesion located in apical segment of left upper 
lobe, seperated from the ﬁrst mass by a thickened pleura were noted. A 
frozen section diagnoses of malignant neoplasm was given for the mass 
lesion invading thorasic outlet. Therefore, this mass was exsized along 
with wedge resection of the second apical lung lesion. The exsized ﬁrst 
mass measured 5x4x0,7 cm, it was hard and gray to brown colored. 
The wedge resection covered with visceral pleura measured 8x5,5x 
2cm and contained an inﬁltrative hard, grayish white mass of 2 cm 
diameter without pleural involvement.These two tumors,one of which 
was primarily localized in pleura with limited extension into the lung 
parenchyma and the other mainly localized in the lung parenchyma 
had different morphologic and immune phenotypic features. Light 
microscopy of the tumor involving mainly pleura showed a malignant 
epithelial tumor with mainly diffuse patern with focal papillary areas. 
The differential diagnoses of this tumor included primary or metastatic 
adenocarcinoma and epithelial mesothelioma. Mucicarmine stain was 
negative while PAS and D-PAS stains were positive in some tumor 
cells. Tumor cells were pankeratin and vimentin positive, TTF-1, CK7, 
CK 5/6, CK20, CEA, calretinin, NSE, synaptophysin and chromogranin 
negative. There was focal CD15 positivity. Although CK7 and TTF-1 
were negative, these morphologic, histochemical and immunohisto-
chemical features suggested that this tumor might represent an undiffer-
entiated large cell or poorly differentiated pulmonary adenocarcinoma. 
The second tumor localized in lung parenchyma was well differentiated 
adenocarcinoma with mucicarmine positive intracytoplasmic mucine 
secretion. It had CK7, TTF-1 positive and vimentin, CK 5/6 and CK20 
negative immunophenotype. This tumor was intimately associated with 
diffuse neoplastic lymphocytic inﬁltration. Neoplastic lymphocytic 
cells had a monocytoid appearance with formation of occasional lym-
phoepithelial lesions. Lymphocytic tumor cells CD20 positive, CD5, 
CD10, CD23, CD3 and cyclinD1 negative immunophenotype. Because 
of these features, a diagnoses of MALT lymphoma was given. 
To the best of our knowledge our case is the ﬁrst one that presented 
with two different lung carcinomas which had different morphologic 
and immunophenotypic features, one of which was associated with 
multisystemic (lung, stomach,duodenum) extranodal marginal zone 
lymphoma of MALT type.
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Clinicopathological study of bronchogenic carcinoma - a study of 
303 cases
Uddin, Mokhles 
Dhaka Medical College Hospital, Dhaka, Bangladesh
Subjects: 303 patients of bronchogenic carcinoma in the Department 
of Radiotherapy. Dhaka Medical College Hospital. Dhaka from 1st 
January 2000 to 31st December 2005. 
Settings: Department of Radiotherapy, Dhaka Medical College Hospital
Main Outcome Measures: This study reveals a general idea of certain 
clinicopathological aspects of bornchogenic carcinoma prevailing 
amongst the population of Bangladesh.
Results: Males (87.79%) suffered more than females (12.2%) their 
ratio was 7.19:1. Majority of the patients were of elderly age group 
with peak occurrence between 50 and 59 years. More than 90% of the 
patients were smoker. 86.47% chewed betel leaf 68.65% used tea and 
only 19 (6.27%) were alcoholic. More than 60% of the patients were 
lower socioeconomic class and others from middle class family. Ap-
proximately 40% of the patients were illiterate. 37.29% had primary 
education. 12.54% secondary school education. 5.96% higher second-
ary and only 4.62% graduate and above.
Cough (77.89%) was the commonest presenting symptom followed 
by chest pain (66%). Dyspnoea (44.55%). haemoptysis {40.59%}. 
Squamous cell carcinoma (51.82%) was the most common histology 
followed by small cell carcinoma (19.14%). adenocarcinoma (13.86%). 
large cell carcinoma (7.28%). Right lung was effective more and the 
upper lobes were the common sites of involvement.
Conclusion: This study correlates and sometimes differs with the data 
of studies at home and abroad. But reﬂects at least some clinical and 
pathological aspects of bronchial carcinoma in Bangladesh.
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Protein expression and gene amplification of epidermal growth 
factor receptor in non-small cell lung cancer: correlation with 
chemoresponse to gefitinib therapy
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Background: The human epidermal growth factor receptor (HER) 
family of receptor tyrosine kinase has been demonstrated to be overex-
pressed in the majority of NSCLC, leading to the clinical development 
of molecular therapies targeting the epidermal growth factor receptor 
(EGFR). Among the various small molecule inhibitors of tyrosine ki-
nase, geﬁtinib has been approved for clinical use in patients with previ-
ously treated advanced NSCLC. It has shown dramatic effectiveness 
in certain patient subsets, including women, never-smokers, adeno-
carcinomas, and East Asian descents. However, predictive molecular 
markers are yet to be determined. 
Design: EGFR protein overexpression by immunohistochemistry and 
gene ampliﬁcation by chromogenic in situ hybridization (CISH) were 
analyzed in biopsy specimens from 46 patients with advanced NSCLC. 
After failure of ﬁrst-line treatment, 29 had received geﬁtinib. Time 
to progression (TTP) and overall survival (OS) were correlated with 
EGFR status.
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Results: The patients included 23 male patients and 23 female patients 
with a median age of 62 years (mean age, 59.5 years; age range, 37-79 
years). Histologically, the specimens were classiﬁed into 13 cases of 
squamous cell carcinoma and 33 cases of adenocarcinoma. Never-
smokers made up 52.2% (24/46) of patients. EGFR overexpression was 
detected in 80.4% (37/46) of the tumors, and was observed exclusively 
in patients with partial response when compared to those with either 
stable or progressive disease (100% vs 76.3%; p=0.083). EGFR gene 
ampliﬁcation was found in 48.3% (14/29) of the tumors. EGFR protein 
expression showed signiﬁcant association with EGFR gene ampliﬁca-
tion (p=0.024). Median TTP was 6.7 months and OS was 22.6 months. 
OS was longer in female patients (p=0.003) and in patients with geﬁ-
tinib treatment (p=0.025), partial response (p=0.037), adenocarcinoma 
(p=0.007), and lower T (p=0.013). The patients with EGFR overexpres-
sion and/or gene ampliﬁcation had signiﬁcantly prolonged OS (24.4 vs 
12.4 months; p=0.005) and TTP (7.2 vs 3.4 months; p=0.083). Their 
stage tended to be lower (p=0.095). The multivariate analysis with Cox 
proportional hazards model revealed geﬁtinib therapy, sex, response, 
EGFR overexpression and gene ampliﬁcation as signiﬁcant prognostic 
factors (p=0.002, 0.048, 0.033, 0.023 and 0.042, respectively).
Conclusion: EGFR overexpression was associated with improved 
response to geﬁtinib therapy. EGFR protein expression in NSCLC was 
accompanied predominantly, but not exclusively, by gene ampliﬁcation. 
However, EGFR overexpression and/or gene ampliﬁcation was associ-
ated with TTP and OS, therefore, it is important to evaluate both EGFR 
protein expression and gene ampliﬁcation status in identifying patients 
most likely to beneﬁt from geﬁtinib therapy. 
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Clinical significance of the AKT pathway in small cell lung cancer 
and other neuroendocrine tumors
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Background: Dysregulation of the AKT pathway is known to be 
important to develop many types of human cancer. However, little is 
known about the role of the AKT in neuroendocrine tumors of lung 
(NET). We sought to investigate p-Akt, PTEN, p-mTOR, p-TSC2, 
p-S6, and p-eIF4E in a large series of small cell lung cancer (SCLC), 
typical carcinoid (TC), atypical carcinoid (AC), and large cell neu-
roendocrine carcinoma (LCNEC). We also investigated the status of 
p-Erk1/2, which is a member of the RAS/MEK/ERK pathway, and 
interacts with the AKT pathway.
Methods: We immunohistochemically stained a tissue microarray with 
71 SCLC, 50 TC, 30 AC, and 29 LCNEC using antibodies to PTEN, 
p-AKT, p-mTOR, p-TSC2, p-S6, p-eIF4E, and p-Erk1/2. A score for 
each case was made based on distribution and intensity of staining and 
positive thresholds set according to clinical/molecular correlations. Fol-
low-up was available in 133 cases. Kaplan Meier survival analysis and 
chi-square statistics were made using JMP 5.0.
Results: In SCLC many correlations were found: negative p-Akt 
correlated with negative p-TSC2, p-S6, and p-eIF4E (p=0.025, 0.009, 
0.010): negative p-TSC2 correlated with negative p-mTOR, p-S6, and 
eIF4E (p=0.004, 0.007, and 0.011): negative p-Erk1/2 correlated with 
negative p-TSC2 and p-S6 (p=0.012, 0.033). Expression of PTEN in 
SCLC cases was attenuated compared to TC and AC (p<0.001). Over-
expression of p-Akt and p-S6 was observed in SCLC compared to in 
TC or AC (p=0.044, 0.010), whereas overexpression of p-TSC2 was in 
TC or AC comparing to SCLC (p<0.001). Although p-Akt was overex-
pressed cases where PTEN was preserved (p=0.002), cases with p-Akt 
overexpression and PTEN preserved staining were not correlated with 
survival compared to the other cases. Survival correlations were found 
for all NET and in SCLC with overexpression of eIF4E. Additionally 
cases with preserved staining of PTEN showed signiﬁcantly better 
survival among all NET.
Conclusion: Dysregulation of the AKT pathway is important in not 
only SCLC but other NETs with many interactions between down-
stream factors and prognostic correlations with p-eIF4E and PTEN.
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Responses of total antioxidant status amongst lung cancer patients
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Introduction: Lung cancer is one of the leading cause of death.The 
incidence of lung cancer is up cropping even in the under developing 
country like Nepal (2), where the changing life style, addiction, occupa-
tion hazards, social and epidemiological factors are the major cause of 
cancer in Nepal. scientiﬁc research work claimed that p53 is detected as 
a signiﬁcance role to cause the cancer (3). Our present study encourage 
us due to the number of patient who are provision diagnose as cancer. 
Our research work is mainly focused on the total antioxidant status 
amongst the subjects provisionally diagnosed of lung cancer. 
Method: The study was conducted in lung cancer patients reports 
attending at Medicine and Surgery out patient department,different 
hospitals. This study was a form of pilot studies to asses the antioxidant 
status in cancer patients. A total of 108 subjects (male: 58, female 50) 
were chosen and an age-sex matched healthy controls of 108 subjects 
(male: 55, female 53). A four-day dietary recall was established to 
check the differences in dietary antioxidants intake in both groups. 5 ml 
of blood sample was collected after a written consent from the subjects 
and was stored at -22°C for further analysis. The total antioxidant, su-
per oxide dismutase, and glutathione peroxidase was measured adopt-
ing a ready-made kit procured from RANDOX, Germany. 
Results: Among the cancer patients the total antioxidant was relatively 
lowered and falling in lower borderline range to those observed in 
controls subjects. The results are shown in Table. No. I which is given 
below. 
Discussion: In the present study carried out on lung problem pa-
tients showed that the total antioxidants was lower in cancer patients 
compared to the control groups. This establishes the fact that lowering 
of antioxidants could be the most probable cause of lung cancer. The 
dietary antioxidants intake in the study subjects were similar to that of 
